Scientific Sessions 2025  /  Groundbreaking Trials in Cardiometabolic Therapeutics  /  Discussant: VESALIUS-CV trial
Logo

American Heart Association

  29
  0

Final ID:

Discussant: VESALIUS-CV trial

  • Morris, Pamela  ( MEDICAL UNIVERSITY OF SC , Mt Pleasant , South Carolina , United States )
    • Author Disclosures:
    Pamela Morris: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Groundbreaking Trials in Cardiometabolic Therapeutics

Saturday, 11/08/2025 , 08:30AM - 09:45AM

Late-Breaking Science

More abstracts on this topic:
Discussant

Gaudet Daniel

Effect of Evolocumab in Patients at High Cardiovascular Risk without Prior Myocardial Infarction or Stroke: Primary Results of the VESALIUS-CV trial

Bohula Erin, Wang Huei, Cyrille Marcoli, Paiva Da Silva Lima Gabriel, Giugliano Robert, Sabatine Marc, Marston Nicholas, Bhatia Ajay, De Ferrari Gaetano Maria, Leiter Lawrence, Nicolau Jose, Park Jeong-gun, Murphy Sabina, Walsh Emileigh

More abstracts from these authors:
History and future of lipid therapeutics- a time of Renaissance

Rader Daniel, Morris Pamela

Treatment Implications of LDL-Cholesterol and Apolipoprotein B Discordance: Insights from the Very Large Database of Lipids (VLDbL) and the National Health and Examination Survey (NHANES)

Peng Allison, Blumenthal Roger, Martin Seth, Zahid Sohail, Gianos Eugenia, Shapiro Michael, Navar Ann Marie, Marvel Francoise, Rodriguez Fatima, Soffer Daniel, Morris Pamela

You have to be authorized to contact abstract author. Please, Login
Not Available